X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ONCOGENE

期刊標題檢索 ONCOGENE 最新評論: How long after acceptance will I receive the proof? Do I need to proo... (2024-06-02)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ONCOGENE]您好,您是該頁面的第 200844 位訪客。

期刊簡介
期刊名稱ONCOGENE ONCOGENE
LetPub Score
9.0
51 ratings
Rate

Reputation
9.7

Influence
8.5

Speed
8.3

期刊簡稱ONCOGENE
ISSN0950-9232
E-ISSN1476-5594
h-index312
CiteScore
CiteScoreSJRSNIPCiteScore Rank
15.302.3341.368
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q118 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q135 / 410
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cancer Research
Q125 / 230

自引率 (2023-2024)1.40%自引率趨勢
掲載範囲
Oncogene aims to make substantial advances in our knowledge of processes that contribute to cancer by publishing outstanding research. We propagate work that challenges standard conjecture and builds on previous studies, in particular those that lead to establishing new paradigms in the etio-pathogenesis, diagnosis, treatment, or prevention of cancers, and in processes that drive metastatic spread, and provide important insights into cancer biology beyond what has been revealed thus far.
官方網站https://www.nature.com/onc
在線稿件提交https://mts-onc.nature.com/
開放訪問No
出版商Springer Nature
主題領域医学
出版國/地區ENGLAND
發行頻率週刊
創刊年1997
每年文章數266每年文章數趨勢
黃金OA百分比39.26%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ136/313
CELL BIOLOGYSCIEQ140/205
GENETICS & HEREDITYSCIEQ116/191
ONCOLOGYSCIEQ142/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0950-9232%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 31.25%
參考鏈接
相關期刊 【ONCOGENE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1278756
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS570951
    JOURNAL OF BIOLOGICAL CHEMISTRY395990
    NUCLEIC ACIDS RESEARCH338132
    CELL298252
    FASEB JOURNAL267140
    International Journal of Biological Sciences236835
    PLANT SCIENCE228209
    Molecular Cancer212741
    ACS Chemical Biology196502
  •  

    ONCOGENE ONCOGENE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/28)
  [ONCOGENE] 的評論撰寫評論
作者: xiyou2019


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-02 15:40:03 評論於
How long after acceptance will I receive the proof? Do I need to proofread before making payment? Should I send emails to the corresponding author for all of this? It has been almost a week since my acceptance, but I have not received any further instructions. My supervisor is very busy and may have overlooked the email without informing me
(0) 讚! | xiyou2019

作者: xiyou2019


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-02 15:36:30 評論於
My order has been officially accepted, they said it will be transferred to the production team within a few hours, but it's been almost a week and I haven't received any proof or payment emails yet? I wanted to ask how long will it take for the next action, should I pay first or see the proof first?
(0) 讚! | xiyou2019

作者: Griselda Funk


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-25 19:54:43 評論於
Laughing to death, wish you good luck
(0) 讚! | Griselda Funk

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 21:31:31 評論於
I chose Open, Oncogene is really expensive
(0) 讚! | Zona Patrick

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 10:11:13 評論於
It might not be immediate, maybe just a few minutes later. Hope you receive it soon~
(0) 讚! | Zona Patrick

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 10:00:08 評論於
You can only choose one submission system, just make sure to note it in the Manuscript
(0) 讚! | Zona Patrick

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 08:00:32 評論於
I don't know about this one ? I chose the OA, which is more expensive
(0) 讚! | Zona Patrick

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-08 19:06:00 評論於
May I ask if the change of my status from "pending review" to "waiting revision" means I will immediately receive an email for revisions? My initial review took 82 days, and now it has been two days since my submission status changed to "waiting revision," but I have not received any email asking for revisions
(0) 讚! | 璃沙癸巳

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-08 18:16:19 評論於
Case cracked, brothers. Two reviewers in the boss's trash, 30 questions assigned, with 60 days to complete. It's gonna be a tight schedule, I'm off to work now
(0) 讚! | 璃沙癸巳

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-08 11:07:02 評論於
How are you doing? I have also made a decision and am waiting for a revision, but it's been two or three days and I still haven't received an email, so I'm feeling anxious
(0) 讚! | 璃沙癸巳

作者: 璃沙癸巳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-06 14:06:46 評論於
Can anyone explain why my article has been under review for 85 days, the submission status is "decision made" and "waiting revision", but I still haven't received any revision email after 2 days?
(0) 讚! | 璃沙癸巳

作者: 宇杰酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-01 11:40:00 評論於
Hello! Is this magazine only for corresponding authors to reply to emails? Is there a word limit for the manuscript?
(0) 讚! | 宇杰酱大魔王

作者: 宇杰酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-01 08:28:38 評論於
Hello! Does this magazine only send emails to corresponding authors? Is there a word limit for the manuscript?
(0) 讚! | 宇杰酱大魔王

作者: 雅云小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-27 10:31:52 評論於
How do I set up shared communication? The Corresponding Author field only shows one option, there are no additional choices
(0) 讚! | 雅云小哥哥

作者: 雅云小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-26 12:44:34 評論於
I also want to know if non-OA also requires page charges? I see it costs $243 per page, it's so expensive
(0) 讚! | 雅云小哥哥

作者: 博延公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-25 11:41:28 評論於
Thank you very much. So, is your choice to open or not to open?
(0) 讚! | 博延公子

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 20:06:33 評論於
My situation is special, and I happened to receive the payment email almost 20 days after Christmas break
(0) 讚! | Zona Patrick

作者: 春蕊来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 18:48:25 評論於
How did it go?
(0) 讚! | 春蕊来了

作者: 新柔mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-17 20:31:36 評論於
Hello, how long does it usually take to receive the payment email after making a decision?
(0) 讚! | 新柔mm

作者: 春海小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-15 15:53:55 評論於
Can I ask my comrade what the other reviewer replied? I'm so scared
(0) 讚! | 春海小公主

作者: zzzmianyi


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 20:42:34 評論於
Submitted in September 23rd, received first round of comments in early December asking for additional experiments, submitted in February, received second round of comments twenty days later asking for further experiments, just resubmitted in April, not sure about the outcome
(1) 讚! | zzzmianyi

作者: 春海小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-13 20:44:36 評論於
Does "QC started" refer to internal audit in the editing department? Is it possible that it's still with the editor?
(0) 讚! | 春海小公主

作者: 岭南芮静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-14 19:26:04 評論於
How did it go?
(0) 讚! | 岭南芮静

作者: 一条小秋华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-07 18:54:54 評論於
Why does the editorial department still require non-OA selections to pay publication fees? Have they all refused to publish without payment?
(0) 讚! | 一条小秋华

作者: Zona Patrick


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-31 22:06:14 評論於
Please translate the following passage into English and Japanese, and title them ":" and ":"
(0) 讚! | Zona Patrick

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/28)

開始撰寫 [ONCOGENE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*